
Genetic Engineering in Agriculture Market
Genetic Engineering in Agriculture Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
Genetic Engineering in Agriculture Market Size and Trend Analysis
What Is the Growth Outlook for Agricultural Genetic Engineering?
The global Genetic Engineering in Agriculture market size is expected to be valued at US$ 38.0 billion in 2026 and projected to reach US$ 60.3 billion by 2033, growing at a CAGR of 6.8% between 2026 and 2033.
These figures count seed and trait value together with enabling tools, reagents and services, not the far larger downstream value of crops grown from engineered seed. On that basis, value grew at a 5.6% CAGR between 2020 and 2025. Three forces now set the pace. Trait renewal cycles are shortening as weed and insect populations erode the usefulness of older events, pushing growers toward newer stacked products. Gene editing has lowered the cost and time of developing a trait, opening crops that never justified a transgenic programme. Engineered microbial seed and soil products have added a product class sold alongside seed. Growth is steady rather than explosive, because regulatory divergence and public acceptance still gate where products can be sold.
Key Report Takeaways
- By Technology: Transgenic modification held 66% share in 2026, while gene editing is projected to expand at a 12.4% CAGR through 2033, driven by jurisdictions that treat edits without foreign DNA outside the transgenic approval pathway.
- By Product Type: Genetically engineered seeds and traits held 70% share in 2026, while microbial seed and soil products are projected to expand at a 10.6% CAGR, driven by nitrogen management pressure and fertiliser cost volatility.
- By Trait Type: Stacked traits held 45% share in 2026, while quality and output traits are projected to expand at a 10.8% CAGR through 2033, driven by processor and retailer demand for compositional and shelf-life characteristics.
- By Crop Type: Maize held 38% share in 2026, while fruits, vegetables and other crops are projected to expand at a 10.2% CAGR through 2033, driven by editing costs low enough to justify smaller-acreage programmes.
- By Geography: North America held 42% share in 2026, while Asia Pacific is projected to expand at a 9.0% CAGR through 2033, driven by national approvals of edited crops and large domestic breeding programmes.
Global Genetic Engineering in Agriculture Market Trends and Insights
Drivers Impact Analysis
Two structural shifts explain most of the forecast acceleration in agricultural biotechnology spending.
| Driver | Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
| Lighter-touch regulatory treatment of gene-edited crops in several jurisdictions | High | North America, Latin America, Asia Pacific | Medium term (2–4 years) |
| Resistance pressure forcing renewal of insect and herbicide tolerance trait stacks | High | Global | Long term (≥4 years) |
Streamlined Gene-Editing Rules Shorten the Path From Laboratory to Commercial Seed
Regulatory treatment is now the single largest determinant of development cost in crop biotechnology. Where an edited plant containing no foreign DNA is handled outside the transgenic approval pathway, the dossier, field trial and review burden falls sharply. That change brings forward revenue, lowers the capital a developer must raise before launch, and makes programmes viable for mid-sized firms and public breeding institutes that could never fund a full transgenic submission.
The mechanism is procedural rather than scientific. The USDA APHIS SECURE rule exempts certain modifications that could have been achieved through conventional breeding from permitting under 7 CFR part 340. Argentina assesses gene-edited products case by case and treats those without inserted foreign DNA as conventional, and Japan applies a notification route on similar reasoning. Developers routinely sequence their launches through these jurisdictions first.
Resistance Pressure Forces Continuous Renewal of Insect and Herbicide Tolerance Stacks
Trait renewal is a recurring, non-discretionary purchase rather than a one-off upgrade. Weed populations resistant to glyphosate and other modes of action, and insect populations with reduced susceptibility to individual Bt proteins, erode the field performance of established transgenic crop traits. Growers respond by buying newer stacks that combine multiple herbicide tolerances and several insecticidal proteins, which carry higher technology fees and shorten the commercial life of each generation.
The causal mechanism is selection pressure applied across very large contiguous areas. When a single mode of action dominates a cropping region, resistant biotypes spread quickly. Regulators have reinforced the response: EPA registrations for insect-resistant maize and cotton impose structured refuge requirements and resistance management plans, and some single-protein products have been phased toward pyramided alternatives. Each cycle pulls the installed base onto newer, higher-priced genetics.
Restraints Impact Analysis
Two constraints shape how much of the technical opportunity in this market can actually be commercialised.
| Restraint | Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
| Divergent national approval regimes and asynchronous import authorisation | High | Global | Long term (≥4 years) |
| Public opposition and consumer acceptance limits, strongest in Europe | High | Europe, Asia Pacific | Long term (≥4 years) |
Divergent Approval Regimes Create Trade Risk That Delays Commercial Launch
Approval asymmetry between jurisdictions is the most commercially damaging constraint in agricultural biotechnology. A trait cleared for cultivation in one country may remain unauthorised for import in a major buying market, and most grain supply chains cannot segregate reliably at scale. Exporters simply refuse delivery of unapproved events, and seed firms delay launch until key import markets have cleared the product, which can add years of carrying cost to a completed development programme.
The structural cause is that approvals are national and not synchronised. The European Union operates authorisation under Directive 2001/18/EC and Regulation (EC) No 1829/2003, with a zero-tolerance position on unauthorised events in imported consignments. The Cartagena Protocol on Biosafety governs transboundary movement separately. Grain handlers and crushers, rather than regulators, ultimately bear the detection and rejection risk.
Consumer and Civil-Society Opposition Restricts Market Access in Sensitive Geographies
Public acceptance limits where engineered products can be sold regardless of their regulatory status. Opposition is strongest in Europe, where civil-society organisations and several national governments argue that the technology carries unresolved ecological and corporate-concentration risks, and where retailers have long maintained non-GM sourcing policies. Developers counter that approved products have passed extensive safety assessment. The commercial effect is the same either way: cultivation is minimal across most of the region, and food-chain buyers price segregation into their contracts.
The underlying cost source is identity preservation, not the technology itself. Maintaining non-GM channels requires dedicated storage, separate transport, documented traceability and routine testing at multiple points. Labelling duties add a second layer, with the European Union requiring GM labelling above defined thresholds and the United States Bioengineered Food Disclosure Standard applying its own disclosure rules.
Market Opportunities
Edited Horticultural and Specialty Crops Open a Pool Beyond Four Row Crops
Fruit, vegetable and specialty crop traits represent the clearest untapped revenue pool in agricultural genetic engineering. Commercial activity has concentrated for three decades on maize, soybean, cotton and canola, because only those areas could repay a transgenic development programme. Editing costs have fallen far enough that a trait addressing browning, shelf life, disease resistance or flavour in a smaller crop can now recover its development spend, and the resulting products often reach consumers as a visible benefit rather than an agronomic one.
Produce marketers, processors and retailers create the demand, since waste reduction and consistent quality translate directly into margin. Seed firms serving horticulture, university programmes and specialist developers are positioned to capture it. Regulatory treatment supports the shift, because several jurisdictions assess edited plants without foreign DNA outside the transgenic route, which makes small-acreage economics workable.
Engineered Microbial Products Create a Recurring Pool Alongside Genetically Modified Seeds
Microbial seed and soil products open a revenue stream that renews every season independently of trait licensing. Engineered nitrogen-fixing and nutrient-mobilising organisms, applied as seed treatments or in-furrow products, are sold per hectare each year rather than embedded in a seed price. That economics suits suppliers seeking recurring revenue, and it reaches growers of crops that carry no engineered genetics at all, widening the addressable base well beyond the transgenic row-crop footprint.
Row-crop growers facing volatile fertiliser prices and tightening nutrient-runoff rules generate most of the demand, with processors and food companies adding pressure through supply-chain emissions targets. Fermentation scale-up capability and strain engineering platforms determine who can supply it. Independent agronomic validation remains the gating factor, since performance varies by soil and season, and buyers increasingly require multi-site trial evidence.
Segment Analysis
By Technology: Transgenic Methods Hold the Installed Base While Gene Editing Advances Fastest
Transgenic modification held 66% of market value in 2026, because the commercially dominant insect resistance and herbicide tolerance traits are all insertion events with decades of approvals, field data and licensing infrastructure behind them. Switching that base is slow and expensive. Gene editing grows fastest at a 12.4% CAGR, since CRISPR gene editing in crops removes the need to introduce foreign DNA, cuts development timelines and qualifies for lighter review in several jurisdictions. RNA interference approaches occupy a narrower position, used where sequence-specific pest control or compositional change suits the mechanism. Microbial and synthetic biology methods apply engineering outside the plant genome entirely, in organisms applied to seed or soil. The business implication is a widening split between a large, slowly renewing transgenic franchise and a faster, more fragmented editing pipeline that includes many developers without their own seed distribution.
By Product Type: Seeds and Traits Dominate Value as Microbial Products Scale Quicker
Genetically engineered seeds and traits accounted for 70% of value in 2026, the dominant line, because genetically modified seeds capture trait value through seed price and technology fees collected at the point of sale. The channel is established, the intellectual property is enforceable, and growers repurchase every season. Microbial seed and soil products expand fastest at a 10.6% CAGR, driven by nutrient management pressure and the appeal of a product sold per hectare per year. Enabling tools, reagents and services form a smaller but strategically important line, covering editing reagents, transformation services, genotyping, phenotyping and regulatory dossier support that developers increasingly outsource. Genetically engineered animals and aquaculture remain a modest contributor, constrained by approval timelines and consumer acceptance. For suppliers, the implication is that recurring, non-seed revenue is becoming a deliberate portfolio objective.
By Trait Type: Stacked Traits Lead While Quality and Output Characteristics Grow Quickest
Stacked traits represented 45% of market value in 2026, the largest category, because growers in the Americas now buy combined packages rather than single characteristics, and each added protein or tolerance raises the technology fee. Stacking is also the primary resistance management response. Quality and output traits grow fastest at a 10.8% CAGR, covering oil composition, protein content, reduced browning, shelf life, disease resistance and drought tolerance, where the value accrues to processors, retailers or consumers rather than only to field agronomy. Herbicide tolerance remains the most widely planted single trait by area, and insect resistance anchors cotton and maize protection in regions with heavy pest pressure. The commercial consequence is that trait developers increasingly negotiate with food companies and processors, not only with growers and seed distributors.
By Crop Type: Maize Anchors Trait Value While Specialty Crops Expand Most Rapidly
Maize held 38% of market value in 2026, the largest crop, because it combines a very large planted area across the United States, Brazil, Argentina and Europe with high seed prices and the most complex trait stacks sold anywhere. Soybean follows closely, led by herbicide tolerance packages across the Americas. Fruits, vegetables and other crops grow fastest at a 10.2% CAGR, as editing economics make rice, wheat, potato, banana, tomato and similar programmes viable for the first time. Cotton remains strategically important in India, China, the United States and Brazil, where insect resistance underpins yields. Canola contributes steady value through herbicide tolerance and oil composition work. The implication is that crop diversity in this market will widen considerably, reducing dependence on four commodity programmes.
Geography Analysis
Which Region Is Leading the Genetic Engineering in Agriculture Market?
North America leads the genetic engineering in agriculture market with 42% share in 2026, growing at a 5.8% CAGR, because it combines the largest commercial trait acreage with the deepest research base and the clearest regulatory pathway for edited crops. The United States supplies most of the total, with Canada adding canola, maize and soybean programmes.
Three causes sustain the position. Adoption of insect-resistant and herbicide-tolerant maize, soybean, cotton and canola is near saturation, so value rises through stack complexity and seed pricing rather than through new area. The coordinated framework shared by USDA APHIS, the EPA and the FDA gives developers a predictable route. Venture and corporate funding for editing platforms is concentrated here, which keeps the development pipeline unusually dense.
Europe Remains a Research Base With Minimal Commercial Cultivation Under Strict Authorisation Rules
Europe held 8% share in 2026, growing at a 3.6% CAGR, the lowest of any region, because authorisation under Directive 2001/18/EC and Regulation (EC) No 1829/2003 is demanding and cultivation is politically contested. The Court of Justice of the European Union confirmed that organisms obtained by mutagenesis techniques fall within the GMO directive, which extended the same regime to many edited plants.
Value here is concentrated in research, breeding technology and import authorisations rather than planted area. Spain and Portugal account for most of the limited insect-resistant maize cultivation. The European Commission has proposed a separate regulation for plants obtained by certain new genomic techniques, which supporters say would align review with risk and opponents argue would weaken traceability and choice. Its outcome is the single largest variable for the region.
Which Region Is Growing Fastest in the Genetic Engineering in Agriculture Market?
Asia Pacific is the fastest-growing geography at a 9.0% CAGR through 2033, holding 18% share in 2026, because several governments have moved from restrictive positions toward structured approval routes for edited crops while retaining large public breeding capacity. China, India, Japan, Australia and the Philippines account for most of the activity.
China has expanded approvals for biotech maize and soybean and funds substantial public gene-editing research, which is the principal reason for the regional growth rate. India’s insect-resistant cotton area remains among the world’s largest, though approval of engineered food crops stays politically contested. Japan applies a notification route for edited products without foreign DNA, and Australia has defined similar carve-outs. The limiting factors are consumer sensitivity in several markets and uneven seed-sector enforcement of intellectual property.
Latin America Delivers the Largest Transgenic Planted Area Outside the United States
Latin America held 27% of the market in 2026, growing at a 7.9% CAGR, because Brazil and Argentina together plant one of the world’s largest transgenic crop areas across soybean, maize and cotton. Paraguay, Uruguay, Bolivia and Colombia add meaningful area, and Brazil has also approved engineered sugarcane and a drought-tolerant wheat event.
Regulatory practice supports this scale. Brazil’s CTNBio and Argentina’s CONABIA both operate established biosafety review systems, and Argentina pioneered the case-by-case approach that treats edits without inserted foreign DNA as conventional. Barriers persist: farm-saved seed and informal multiplication erode trait fee collection, currency volatility complicates multi-season licensing, and export dependence makes growers sensitive to buyer acceptance abroad. The clearest opportunity is edited traits for second-season maize and for regionally important crops.
Middle East & Africa Advances Slowly Through Biosafety Capacity and Drought Tolerance Programmes
Middle East & Africa held 5% share in 2026, growing at a 7.0% CAGR from a small base, with South Africa, Sudan, Nigeria, Kenya, Ethiopia and Egypt accounting for most activity. South Africa has cultivated insect-resistant and herbicide-tolerant maize, soybean and cotton for many years and has the region’s most developed biosafety system.
Constraints are institutional as much as technical. Several countries lack staffed regulatory authorities able to review dossiers, seed distribution networks are thin, and policy direction shifts with changes of government. Opposition campaigns and uncertainty about European import preferences also weigh on national decisions. The most promising change is work on drought-tolerant and pest-resistant maize, cowpea and cassava through public and philanthropic programmes, which targets staple crops that commercial developers have historically ignored.
Competitive Landscape
The genetic engineering in agriculture market is highly concentrated at the trait and seed layer and far more fragmented at the technology layer. A small group of integrated crop science companies controls most commercial transgenic events, the germplasm they are bred into, and the distribution that reaches growers. That position rests on three decades of regulatory dossiers, cross-licensing agreements and seed brand ownership, which together form a barrier that capital alone cannot overcome. Around this core sits a wide field of editing platforms, trait discovery firms, microbial developers and contract research providers, most without their own route to the farm gate.
Competition turns first on freedom to operate and regulatory capability. Access to editing intellectual property, the ability to assemble an approvable dossier, and relationships with authorities in the markets that matter for export often decide whether a promising trait is commercialised. Beyond that, firms compete on germplasm quality, breadth of stacks, distribution reach and digital agronomy services bundled with seed. New entrants arrive mainly as specialists: editing firms licensing traits into established germplasm, fermentation companies building engineered microbial products, and public institutes releasing edited varieties in staple crops.
Strategic activity concentrates on partnership rather than ownership. Incumbents license external editing platforms and in-license traits instead of building every capability internally, while smaller developers trade distribution access for a share of value. Investment has shifted toward shortening breeding cycles through genomic selection and automated phenotyping, and toward microbial products that sit outside trait licensing disputes entirely.
Strategic direction is converging on two themes: moving earlier into crops and geographies that transgenic economics never reached, and building regulatory and stewardship capability as a competitive asset rather than a compliance cost.
Recent Industry Developments
- July 2018: The Court of Justice of the European Union ruled in Case C-528/16 that organisms obtained by mutagenesis techniques are GMOs subject to Directive 2001/18/EC – it brought many gene-edited plants inside the authorisation regime and effectively froze commercial editing programmes across the region.
- May 2020: USDA APHIS published the SECURE rule revising 7 CFR part 340, exempting certain plant modifications achievable through conventional breeding from permitting – it cut development cost and timelines enough for smaller developers and public institutes to pursue commercial traits.
- January 2022: Mandatory compliance began with the United States National Bioengineered Food Disclosure Standard, requiring disclosure of bioengineered food on labels – it replaced a patchwork of state rules with one federal duty and set recordkeeping obligations through the food supply chain.
- July 2023: The European Commission adopted a proposal for a regulation on plants obtained by certain new genomic techniques, creating a separate category with a lighter route for some edited plants – it reopened the question of whether the region’s rules will continue to diverge from those of major exporters.
- February 2024: The European Parliament adopted its first-reading position on the proposed new genomic techniques regulation, backing a two-tier approach while seeking stricter labelling and traceability than proposed – it signalled that acceptance and consumer choice remain central to the region’s position.
Companies Covered in the Report
- Bayer AG
- Corteva Agriscience
- BASF SE
- Syngenta Group
- KWS SAAT SE & Co. KGaA
- Groupe Limagrain
- Pivot Bio, Inc.
- Inari Agriculture, Inc.
- Pairwise Plants LLC
- Cibus, Inc.
- Tropic Biosciences UK Limited
- Benson Hill, Inc.
- Ginkgo Bioworks Holdings, Inc.
- Genus plc
- AquaBounty Technologies, Inc.
Genetic Engineering in Agriculture Market Report Scope
| Metric | Value |
| Study Period | 2020–2033 |
| Market Size 2026 | US$ 38.0 Billion |
| Market Size 2033 | US$ 60.3 Billion |
| CAGR 2026–2033 | 6.8% |
| Absolute Dollar Opportunity | US$ 22.3 Billion |
| Largest Market | North America (42% share in 2026) |
| Fastest-Growing Market | Asia Pacific (9.0% CAGR) |
| Market Concentration | High |
| Major Players | Bayer AG, Corteva Agriscience, BASF SE, Syngenta Group, KWS SAAT SE & Co. KGaA |
Genetic Engineering in Agriculture Market Segmentation
Technology
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
Product Type
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
Trait Type
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
Crop Type
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Executive Summary
- Global Genetic Engineering in Agriculture Market Snapshot
- Market Size and Trend Analysis 2020–2033
- Historical Growth 2020–2025
- Base Year 2025
- Forecast Outlook 2026–2033
- Key Report Takeaways
- Market Overview
- Market Definition and Report Scope
- Market Dynamics
- Drivers
- Streamlined Gene-Editing Rules Shorten the Path From Laboratory to Commercial Seed
- Resistance Pressure Forces Continuous Renewal of Insect and Herbicide Tolerance Stacks
- Restraints
- Divergent Approval Regimes Create Trade Risk That Delays Commercial Launch
- Consumer and Civil-Society Opposition Restricts Market Access in Sensitive Geographies
- Market Opportunities
- Edited Horticultural and Specialty Crops Open a Pool Beyond Four Row Crops
- Engineered Microbial Products Create a Recurring Pool Alongside Genetically Modified Seeds
- Drivers
- Segment Analysis
- By Technology: Transgenic Methods Hold the Installed Base While Gene Editing Advances Fastest
- By Product Type: Seeds and Traits Dominate Value as Microbial Products Scale Quicker
- By Trait Type: Stacked Traits Lead While Quality and Output Characteristics Grow Quickest
- By Crop Type: Maize Anchors Trait Value While Specialty Crops Expand Most Rapidly
- Global Genetic Engineering in Agriculture Market Outlook, 2020–2033
- Global Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
- Global Genetic Engineering in Agriculture Market Outlook, by Product Type, Value (US$ Billion), 2020–2033
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
- Global Genetic Engineering in Agriculture Market Outlook, by Trait Type, Value (US$ Billion), 2020–2033
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
- Global Genetic Engineering in Agriculture Market Outlook, by Crop Type, Value (US$ Billion), 2020–2033
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
- Global Genetic Engineering in Agriculture Market Outlook, by Region, Value (US$ Billion), 2020–2033
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Global Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- North America Genetic Engineering in Agriculture Market Outlook, 2020–2033
- Regional Market Leadership
- North America Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
- North America Genetic Engineering in Agriculture Market Outlook, by Product Type, Value (US$ Billion), 2020–2033
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
- North America Genetic Engineering in Agriculture Market Outlook, by Trait Type, Value (US$ Billion), 2020–2033
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
- North America Genetic Engineering in Agriculture Market Outlook, by Crop Type, Value (US$ Billion), 2020–2033
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
- North America Genetic Engineering in Agriculture Market Outlook, by Country, Value (US$ Billion), 2020–2033
- United States Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- United States Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- United States Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- United States Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Canada Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Canada Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Canada Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Canada Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Europe Genetic Engineering in Agriculture Market Outlook, 2020–2033
- Europe Remains a Research Base With Minimal Commercial Cultivation Under Strict Authorisation Rules
- Europe Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
- Europe Genetic Engineering in Agriculture Market Outlook, by Product Type, Value (US$ Billion), 2020–2033
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
- Europe Genetic Engineering in Agriculture Market Outlook, by Trait Type, Value (US$ Billion), 2020–2033
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
- Europe Genetic Engineering in Agriculture Market Outlook, by Crop Type, Value (US$ Billion), 2020–2033
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
- Europe Genetic Engineering in Agriculture Market Outlook, by Country, Value (US$ Billion), 2020–2033
- Spain Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Spain Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Spain Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Spain Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Portugal Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Portugal Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Portugal Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Portugal Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Asia Pacific Genetic Engineering in Agriculture Market Outlook, 2020–2033
- Regional Growth Outlook
- Asia Pacific Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
- Asia Pacific Genetic Engineering in Agriculture Market Outlook, by Product Type, Value (US$ Billion), 2020–2033
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
- Asia Pacific Genetic Engineering in Agriculture Market Outlook, by Trait Type, Value (US$ Billion), 2020–2033
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
- Asia Pacific Genetic Engineering in Agriculture Market Outlook, by Crop Type, Value (US$ Billion), 2020–2033
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
- Asia Pacific Genetic Engineering in Agriculture Market Outlook, by Country, Value (US$ Billion), 2020–2033
- China Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- China Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- China Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- China Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- India Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- India Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- India Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- India Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Japan Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Japan Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Japan Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Japan Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Australia Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Australia Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Australia Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Australia Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Philippines Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Philippines Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Philippines Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Philippines Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Latin America Genetic Engineering in Agriculture Market Outlook, 2020–2033
- Latin America Delivers the Largest Transgenic Planted Area Outside the United States
- Latin America Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
- Latin America Genetic Engineering in Agriculture Market Outlook, by Product Type, Value (US$ Billion), 2020–2033
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
- Latin America Genetic Engineering in Agriculture Market Outlook, by Trait Type, Value (US$ Billion), 2020–2033
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
- Latin America Genetic Engineering in Agriculture Market Outlook, by Crop Type, Value (US$ Billion), 2020–2033
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
- Latin America Genetic Engineering in Agriculture Market Outlook, by Country, Value (US$ Billion), 2020–2033
- Brazil Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Brazil Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Brazil Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Brazil Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Argentina Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Argentina Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Argentina Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Argentina Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Paraguay Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Paraguay Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Paraguay Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Paraguay Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Uruguay Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Uruguay Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Uruguay Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Uruguay Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Bolivia Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Bolivia Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Bolivia Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Bolivia Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Colombia Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Colombia Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Colombia Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Colombia Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Middle East & Africa Genetic Engineering in Agriculture Market Outlook, 2020–2033
- Middle East & Africa Advances Slowly Through Biosafety Capacity and Drought Tolerance Programmes
- Middle East & Africa Genetic Engineering in Agriculture Market Outlook, by Technology, Value (US$ Billion), 2020–2033
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
- Middle East & Africa Genetic Engineering in Agriculture Market Outlook, by Product Type, Value (US$ Billion), 2020–2033
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
- Middle East & Africa Genetic Engineering in Agriculture Market Outlook, by Trait Type, Value (US$ Billion), 2020–2033
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
- Middle East & Africa Genetic Engineering in Agriculture Market Outlook, by Crop Type, Value (US$ Billion), 2020–2033
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
- Middle East & Africa Genetic Engineering in Agriculture Market Outlook, by Country, Value (US$ Billion), 2020–2033
- South Africa Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- South Africa Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- South Africa Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- South Africa Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Sudan Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Sudan Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Sudan Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Sudan Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Nigeria Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Nigeria Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Nigeria Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Nigeria Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Kenya Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Kenya Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Kenya Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Kenya Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Ethiopia Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Ethiopia Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Ethiopia Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Ethiopia Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Egypt Genetic Engineering in Agriculture Market Outlook, by Technology, 2020–2033
- Egypt Genetic Engineering in Agriculture Market Outlook, by Product Type, 2020–2033
- Egypt Genetic Engineering in Agriculture Market Outlook, by Trait Type, 2020–2033
- Egypt Genetic Engineering in Agriculture Market Outlook, by Crop Type, 2020–2033
- Competitive Landscape
- Market Concentration and Supplier Participation
- Competitive Factors and Strategic Direction
- Recent Industry Developments
- EU Court Mutagenesis Ruling July 2018
- USDA APHIS SECURE Rule Publication May 2020
- U.S. Bioengineered Food Disclosure Compliance January 2022
- EU New Genomic Techniques Regulation Proposal July 2023
- European Parliament New Genomic Techniques Position February 2024
- Company Profiles
- Bayer AG
- Corteva Agriscience
- BASF SE
- Syngenta Group
- KWS SAAT SE & Co. KGaA
- Groupe Limagrain
- Pivot Bio, Inc.
- Inari Agriculture, Inc.
- Pairwise Plants LLC
- Cibus, Inc.
- Tropic Biosciences UK Limited
- Benson Hill, Inc.
- Ginkgo Bioworks Holdings, Inc.
- Genus plc
- AquaBounty Technologies, Inc.
- Appendix
- Research Methodology
- Report Assumptions
- Acronyms and Abbreviations
Technology
- Transgenic modification
- Gene editing
- RNA interference
- Microbial and synthetic biology approaches
Product Type
- Genetically engineered seeds and traits
- Microbial seed and soil products
- Genetically engineered animals and aquaculture
- Enabling tools, reagents and services
Trait Type
- Herbicide tolerance
- Insect resistance
- Stacked traits
- Quality and output traits
Crop Type
- Maize
- Soybean
- Cotton
- Canola
- Fruits, vegetables and other crops
Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Our Research Methodology
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology
Quality Assured
Rigorous Validation Process

Confidentiality Assured
End-to-end Data Security

Custom Research Services
Tailored To Your Objectives
FAQs
The market is valued at US$ 38.0 billion in 2026, counting seed and trait value plus enabling tools and services, excluding downstream crop value.
The market is projected to reach US$ 60.3 billion by 2033, growing at a 6.8% CAGR and creating US$ 22.3 billion in absolute opportunity.
Transgenic modification leads with 66% share in 2026, because established insect resistance and herbicide tolerance events carry decades of approvals and licensing infrastructure.
Gene editing grows fastest at a 12.4% CAGR, while Asia Pacific leads geographic growth at a 9.0% CAGR through 2033.
North America leads with 42% share in 2026, and the trait and seed layer is highly concentrated, while editing and microbial technology suppliers remain fragmented.
Related Reports
Immune Checkpoint Inhibitors Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
The global immune checkpoint inhibitors market is valued at US$52.0 billion in 2026, reaching US$68.0 billion by 2033, growing at a 3.91% CAGR
Geriatric Medicines Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
The global geriatric medicines market is valued at US$412.0 billion in 2026, reaching US$538.0 billion by 2033, growing at a 3.9% CAGR
Pharmaceutical Temperature Controlled Packaging Solutions Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
Pharmaceutical temperature controlled packaging solutions market to grow from US$ 6.86 billion in 2026 to US$ 13.98 billion by 2033 at a 10.7% CAGR.
Dermatology CRO Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
Explore the dermatology CRO market, projected to reach US$ 9.7 billion by 2033 at a 6.6% CAGR, with service, indication and regional insights.
Acetaminophen Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
The global acetaminophen market is valued at US$11.70 billion in 2026, reaching US$15.93 billion by 2033, growing at a 4.5% CAGR
Allergy Diagnostics and Therapeutics Market Size, Share, Insights, Competitive Landscape, and Forecast 2026 to 2033
The global allergy diagnostics and therapeutics market is valued at US$41.50 billion in 2026, reaching US$88.30 billion by 2033, growing at an 11.4% CAGR